These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3141279

  • 1. Serum antibody and ocular responses to murine corneal infection caused by Pseudomonas aeruginosa.
    Berk RS, Montgomery IN, Hazlett LD.
    Infect Immun; 1988 Dec; 56(12):3076-80. PubMed ID: 3141279
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa.
    Preston MJ, Kernacki KA, Berk JM, Hazlett LD, Berk RS.
    Infect Immun; 1992 Mar; 60(3):885-91. PubMed ID: 1541561
    [Abstract] [Full Text] [Related]

  • 3. Antibody hyporesponsiveness in resistant BALB/cJ mice intracorneally infected with Pseudomonas aeruginosa.
    Berk RS, Preston M, Montgomery IN, Hazlett LD, Tse HY.
    Reg Immunol; 1992 Mar; 3(4):186-92. PubMed ID: 2129603
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa.
    Preston MJ, Kernack K, Berk RS.
    Infect Immun; 1993 Jun; 61(6):2713-6. PubMed ID: 8500912
    [Abstract] [Full Text] [Related]

  • 5. Paternal alcohol consumption: effects on ocular response and serum antibody response to Pseudomonas aeruginosa infection in offspring.
    Berk RS, Montgomery IN, Hazlett LD, Abel EL.
    Alcohol Clin Exp Res; 1989 Dec; 13(6):795-8. PubMed ID: 2690665
    [Abstract] [Full Text] [Related]

  • 6. Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.
    Preston MJ, Berk JM, Hazlett LD, Berk RS.
    Infect Immun; 1991 Jun; 59(6):1984-90. PubMed ID: 1903770
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB.
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [Abstract] [Full Text] [Related]

  • 8. Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice.
    Hazlett LD, Zucker M, Berk RS.
    Ophthalmic Res; 1992 Jun; 24(1):32-9. PubMed ID: 1608590
    [Abstract] [Full Text] [Related]

  • 9. Role of complement in murine corneal infection caused by Pseudomonas aeruginosa.
    Cleveland RP, Hazlett LD, Leon MA, Berk RS.
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):237-42. PubMed ID: 6826327
    [Abstract] [Full Text] [Related]

  • 10. Further studies on the genetic control of murine corneal response to Pseudomonas aeruginosa.
    Berk RS, Hazlett LD.
    Rev Infect Dis; 1983 Feb; 5 Suppl 5():S936-40. PubMed ID: 6658287
    [Abstract] [Full Text] [Related]

  • 11. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
    Kernacki KA, Hobden JA, Hazlett LD, Fridman R, Berk RS.
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
    [Abstract] [Full Text] [Related]

  • 12. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD, McClellan S, Kwon B, Barrett R.
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [Abstract] [Full Text] [Related]

  • 13. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS, Priebe GP, Pier GB.
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [Abstract] [Full Text] [Related]

  • 14. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
    Masinick SA, Montgomery CP, Montgomery PC, Hazlett LD.
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
    [Abstract] [Full Text] [Related]

  • 15. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection.
    Kernacki KA, Barrett RP, Hobden JA, Hazlett LD.
    J Immunol; 2000 Jan 15; 164(2):1037-45. PubMed ID: 10623854
    [Abstract] [Full Text] [Related]

  • 16. Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa.
    Beisel KW, Hazlett LD, Berk RS.
    Proc Soc Exp Biol Med; 1983 Apr 15; 172(4):488-91. PubMed ID: 6844357
    [Abstract] [Full Text] [Related]

  • 17. Corneal response to Pseudomonas aeruginosa infection.
    Hazlett LD.
    Prog Retin Eye Res; 2004 Jan 15; 23(1):1-30. PubMed ID: 14766315
    [Abstract] [Full Text] [Related]

  • 18. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling.
    Huang X, Hazlett LD, Du W, Barrett RP.
    J Immunol; 2006 Jul 01; 177(1):548-56. PubMed ID: 16785552
    [Abstract] [Full Text] [Related]

  • 19. Role of innate and adaptive immunity in the pathogenesis of keratitis.
    Hazlett LD.
    Ocul Immunol Inflamm; 2005 Jul 01; 13(2-3):133-8. PubMed ID: 16019672
    [Abstract] [Full Text] [Related]

  • 20. Murine ocular heparanase expression before and during infection with Pseudomonas aeruginosa.
    Berk RS, Dong Z, Alousi S, Kosir MA, Wang Y, Vlodavsky I.
    Invest Ophthalmol Vis Sci; 2004 Apr 01; 45(4):1182-7. PubMed ID: 15037586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.